Immunovant, Inc.
IMVT
$25.75
$0.110.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 994.53M | 521.87M | 598.91M | 713.97M | 374.69M |
| Total Receivables | 1.64M | 1.97M | 1.94M | 2.51M | 2.22M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 46.77M | 49.71M | 50.92M | 51.18M | 35.63M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.04B | 573.55M | 651.76M | 767.66M | 412.54M |
|
|
|||||
| Total Current Assets | 1.04B | 573.55M | 651.76M | 767.66M | 412.54M |
| Net Property, Plant & Equipment | 531.00K | 632.00K | 737.00K | 942.00K | 774.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.92M | 8.78M | 8.94M | 7.62M | 7.62M |
| Total Assets | 1.05B | 582.96M | 661.44M | 776.22M | 420.93M |
|
|
|||||
| Total Accounts Payable | 8.62M | 6.92M | 7.84M | 17.66M | 19.82M |
| Total Accrued Expenses | 57.64M | 55.67M | 44.20M | 50.75M | 48.48M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 98.00K | 23.00K |
| Total Finance Division Other Current Liabilities | -- | 671.00K | 862.00K | 273.00K | -- |
| Total Other Current Liabilities | -- | 671.00K | 862.00K | 273.00K | -- |
| Total Current Liabilities | 66.26M | 63.25M | 52.90M | 68.78M | 68.32M |
|
|
|||||
| Total Current Liabilities | 66.26M | 63.25M | 52.90M | 68.78M | 68.32M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 66.26M | 63.25M | 52.90M | 68.78M | 68.32M |
|
|
|||||
| Common Stock & APIC | 2.58B | 2.00B | 1.97B | 1.95B | 1.48B |
| Retained Earnings | -1.60B | -1.49B | -1.36B | -1.24B | -1.13B |
| Treasury Stock & Other | 1.20M | 1.45M | 1.74M | 1.46M | 2.48M |
| Total Common Equity | 986.14M | 519.71M | 608.54M | 707.45M | 352.62M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 986.14M | 519.71M | 608.54M | 707.45M | 352.62M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 986.14M | 519.71M | 608.54M | 707.45M | 352.62M |
|
|
|||||